STE Q2 Earnings Beat Estimates, Margins Dip, Stock Gains in Aftermarket
STERIS' second-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues. The contraction of both margins is concerning.
| Ticker |
Sentiment |
Impact |
|
HQY
|
Neutral
|
17 %
|
|
PAHC
|
Neutral
|
17 %
|
|
DGX
|
Neutral
|
17 %
|
|
STE
|
Somewhat Bullish
|
42 %
|
